A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune responses and resist immunotherapies. Led by Ludwig Princeton's Lydia Lynch ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Ocelot Bio, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics to treat complications of end-stage liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results